Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.

[1]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[2]  M. Ballow.  Mechanisms of action of intravenous immune serum globulin therapy. , 1994, The Pediatric infectious disease journal.

[3]  B. Björkstén,et al.  Slight steroid‐sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma , 1994, Allergy.

[4]  J. Dambrosia,et al.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. , 1993, The New England journal of medicine.

[5]  W. Fridman,et al.  Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura , 1993, The Lancet.

[6]  J. Bousquet,et al.  HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. , 1993, The American review of respiratory disease.

[7]  S. Durham,et al.  Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. , 1993, The American review of respiratory disease.

[8]  M. Kaliner.  Asthma deaths. A social or medical problem? , 1993, JAMA.

[9]  S. Durham,et al.  PREDNISOLONE TREATMENT IN ASTHMA IS ASSOCIATED WITH MODULATION OF BRONCHOALVEOLAR LAVAGE CELL IL-4, IL-5 AND IFN-GAMMA CYTOKINE GENE EXPRESSION , 1993 .

[10]  P. Newacheck,et al.  Impact of childhood asthma on health. , 1992, Pediatrics.

[11]  S. Mattoli,et al.  Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. , 1992, Chest.

[12]  E. Stiehm.  Recent progress in the use of intravenous immunoglobulin. , 1992, Current problems in pediatrics.

[13]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[14]  D. Leung,et al.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases. , 1992, Clinical reviews in allergy.

[15]  M. Eibl,et al.  Clinical efficacy of intravenous immunoglobulin in patients with severe inflammatory chest disease and IgG3 subclass deficiency , 1991, Clinical and experimental immunology.

[16]  M Takahashi,et al.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. , 1991, The New England journal of medicine.

[17]  E. Gelfand,et al.  An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. , 1991, The Journal of allergy and clinical immunology.

[18]  H. Nelson,et al.  The role of the peak flow meter in the diagnosis and management of asthma. , 1991, The Journal of allergy and clinical immunology.

[19]  S. Durham,et al.  Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. , 1990, The American review of respiratory disease.

[20]  P. Venge,et al.  Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. , 1990, The American review of respiratory disease.

[21]  C. Corrigan,et al.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. , 1990, The American review of respiratory disease.

[22]  R. Rothlein,et al.  Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.

[23]  J. Newburger,et al.  ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASE , 1989, The Lancet.

[24]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[25]  P. Barnes,et al.  A new approach to the treatment of asthma. , 1989, The New England journal of medicine.

[26]  E. Gelfand,et al.  Immunomodulatory effects of intravenous immunoglobulin in severe steroid-dependent asthma. , 1989, Clinical immunology and immunopathology.

[27]  S. Durham,et al.  Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. , 1989, The American review of respiratory disease.

[28]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[29]  P. Fireman,et al.  Morbidity and mortality of asthma. , 1988, Pediatric clinics of North America.

[30]  C. Corrigan,et al.  T LYMPHOCYTE ACTIVATION IN ACUTE SEVERE ASTHMA , 1988, The Lancet.

[31]  S. M. Martin,et al.  YERSINIA ENTEROCOLITICA INFECTIONS AND PORK: THE MISSING LINK , 1987, The Lancet.

[32]  R. Miniero,et al.  Chronic idiopathic thrombocytopenia treated with immunoglobulin. , 1983, Archives of disease in childhood.

[33]  J. Bussel,et al.  Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. , 1983, The Journal of pediatrics.

[34]  E. R. Mcfadden,et al.  Glucocorticoids in acute asthma. A critical controlled trial. , 1983, The American journal of medicine.

[35]  G. Chirico.  High-dose intravenous gammaglobulin therapy for passive immune thrombocytopenia , 1983 .

[36]  A. Hirt,et al.  HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD , 1981, The Lancet.

[37]  P. M. Smith-Moorhouse.  A Social or Medical Problem , 1970 .